Goldman Sachs’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.8M | Buy |
1,340,443
+345,557
| +35% | +$3.29M | ﹤0.01% | 2095 |
|
|
2025
Q1 | $10.4M | Buy |
994,886
+366,183
| +58% | +$3.83M | ﹤0.01% | 2204 |
|
|
2024
Q4 | $14.8M | Sell |
628,703
-41,781
| -6% | -$984K | ﹤0.01% | 2028 |
|
|
2024
Q3 | $24.1M | Sell |
670,484
-1,425,265
| -68% | -$51.2M | ﹤0.01% | 1597 |
|
|
2024
Q2 | $74M | Buy |
2,095,749
+434,661
| +26% | +$15.3M | 0.01% | 814 |
|
|
2024
Q1 | $47.2M | Buy |
1,661,088
+500,316
| +43% | +$14.2M | 0.01% | 1019 |
|
|
2023
Q4 | $15.4M | Sell |
1,160,772
-347,370
| -23% | -$4.62M | ﹤0.01% | 1770 |
|
|
2023
Q3 | $13.5M | Sell |
1,508,142
-501,387
| -25% | -$4.49M | ﹤0.01% | 1778 |
|
|
2023
Q2 | $22.6M | Buy |
2,009,529
+515,079
| +34% | +$5.79M | ﹤0.01% | 1461 |
|
|
2023
Q1 | $17.2M | Buy |
1,494,450
+658,433
| +79% | +$7.59M | ﹤0.01% | 1638 |
|
|
2022
Q4 | $9.69M | Buy |
836,017
+438,447
| +110% | +$5.08M | ﹤0.01% | 2154 |
|
|
2022
Q3 | $5.05M | Buy |
397,570
+331,527
| +502% | +$4.21M | ﹤0.01% | 2634 |
|
|
2022
Q2 | $454K | Sell |
66,043
-12,514
| -16% | -$86K | ﹤0.01% | 4436 |
|
|
2022
Q1 | $757K | Sell |
78,557
-6,061
| -7% | -$58.4K | ﹤0.01% | 4314 |
|
|
2021
Q4 | $1.01M | Buy |
84,618
+45,349
| +115% | +$539K | ﹤0.01% | 4017 |
|
|
2021
Q3 | $637K | Sell |
39,269
-142,877
| -78% | -$2.32M | ﹤0.01% | 4252 |
|
|
2021
Q2 | $3.83M | Buy |
182,146
+79,633
| +78% | +$1.68M | ﹤0.01% | 2986 |
|
|
2021
Q1 | $1.59M | Buy |
102,513
+57,794
| +129% | +$898K | ﹤0.01% | 3572 |
|
|
2020
Q4 | $939K | Sell |
44,719
-133,268
| -75% | -$2.8M | ﹤0.01% | 3488 |
|
|
2020
Q3 | $3.59M | Buy |
+177,987
| New | +$3.59M | ﹤0.01% | 2580 |
|